Arcadia Biosciences Files 2024 Annual Report
Ticker: RKDA · Form: 10-K · Filed: Mar 25, 2025 · CIK: 1469443
| Field | Detail |
|---|---|
| Company | Arcadia Biosciences, Inc. (RKDA) |
| Form Type | 10-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
Arcadia Biosciences filed its 2024 10-K. Full financials and biz details inside.
AI Summary
Arcadia Biosciences, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 25, 2025. The filing details the company's financial performance and business operations. Key financial data and operational aspects are presented within this comprehensive annual report.
Why It Matters
This 10-K filing provides investors and stakeholders with a detailed overview of Arcadia Biosciences' financial health and strategic direction for the past fiscal year, crucial for understanding its current market position and future prospects.
Risk Assessment
Risk Level: medium — The company's SIC code is listed as CRUDE PETROLEUM & NATURAL GAS [1311], which is unusual for a company named Arcadia Biosciences, suggesting potential misclassification or a diversified business model that warrants further investigation.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the 10-K report.)
- 2025-03-25 — Filing Date (The date the 10-K was submitted to the SEC.)
Key Players & Entities
- Arcadia Biosciences, Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end
- 2025-03-25 (date) — Filing date
- CRUDE PETROLEUM & NATURAL GAS [1311] (industry) — Standard Industrial Classification
- 001-37383 (company_id) — SEC File Number
FAQ
What is the primary business of Arcadia Biosciences, Inc. given its SIC code?
The filing lists the Standard Industrial Classification as CRUDE PETROLEUM & NATURAL GAS [1311], which appears incongruent with the company name 'Arcadia Biosciences, Inc.' Further details within the report would be needed to clarify this discrepancy.
What is the SEC file number for Arcadia Biosciences, Inc.?
The SEC file number for Arcadia Biosciences, Inc. is 001-37383.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted to the SEC on March 25, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
Where is Arcadia Biosciences, Inc. headquartered?
Arcadia Biosciences, Inc. is headquartered in Davis, California, with a business address at 202 COUSTEAU PLACE, SUITE 105, DAVIS, CA 95618.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 25, 2025 regarding Arcadia Biosciences, Inc. (RKDA).